|
1
|
Experimental human challenge infections can accelerate clinical malaria vaccine development.
|
Nat Rev Immunol
|
2011
|
2.53
|
|
2
|
Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans.
|
PLoS Pathog
|
2011
|
1.51
|
|
3
|
Cardiac complication after experimental human malaria infection: a case report.
|
Malar J
|
2009
|
1.35
|
|
4
|
A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines.
|
Vaccine
|
2012
|
1.25
|
|
5
|
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection.
|
Br J Haematol
|
2009
|
1.19
|
|
6
|
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
|
Vaccine
|
2006
|
1.16
|
|
7
|
Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum.
|
Eur J Immunol
|
2010
|
1.10
|
|
8
|
Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy.
|
Br J Haematol
|
2010
|
1.04
|
|
9
|
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
|
J Infect Dis
|
2012
|
1.04
|
|
10
|
BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection.
|
J Immunol
|
2014
|
0.92
|
|
11
|
Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naïve adults.
|
PLoS One
|
2012
|
0.89
|